Navigation Links
Veto of California's Condoms in Prisons Bill: "Politics Over Public Health," Says AHF
Date:10/15/2007

AB 1334, (Swanson, D, Oakland), Sponsored by AIDS Healthcare Foundation (AHF), AIDS Project Los Angeles (APLA), and the Southern California HIV/AIDS Coalition (SCHAC) Could Have Helped Reduce Spread of HIV and Other STDs Among California Inmates

Governor Instructs Department of Corrections to Implement Pilot Condom Distribution Program in California; AHF Notes Successful Programs in Jails in Los Angeles, San Francisco, New York, Philadelphia and Washington Already Show Law Could Work Without Threatening Safety and Security

SACRAMENTO, Calif., Oct. 15 /PRNewswire-USNewswire/ -- AB 1334 (Swanson, D-Oakland), The Inmate and Community Public Health & Safety Act, bill that would allow the state of California to permit nonprofit healthcare agencies permission to distribute 'sexual barrier protection devices' (such as condoms and dental dams) to be distributed in California prisons in an effort to reduce the spread of HIV and other sexually transmitted diseases among inmates, was vetoed last evening by Governor Arnold Schwarzenegger, with the Governor's office promising to instruct the Department of Corrections to implement a smaller pilot condom distribution program as an alternative. The bill, which was sponsored by AIDS Healthcare Foundation (AHF), AIDS Project Los Angeles (APLA) and the Southern California HIV/AIDS Coalition (SCHAC), and was authored and carried by Assemblyman Sandre Swanson. AB 1334 would have allowed the state's Department of Corrections to, "...require the director to allow any nonprofit or health care agency to distribute sexual barrier protection devices such as condoms or dental dams to inmates, as specified. The bill would also have established, "...that the distribution of those devices is not a crime nor shall it be deemed to encourage sexual acts between inmates," and that, "...possession of those devices cannot be used as evidence of illegal activity for purposes of administrative sanctions ..."

"We are disapp
'/>"/>

SOURCE AIDS Healthcare Foundation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
2. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
3. Publication Confirms that EpCAM, the Target for Two of Micromets Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers
4. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
5. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
6. Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in Journal of American College of Cardiology
7. Critical Therapeutics Announces the Publication of Data for ZyfloCR (Zileuton) Extended-Release Tablets in the Journal of Asthma
8. Nuvelo Announces Publication of Preclinical Study Results Demonstrating the Potential of NTB-A as a New Target for Leukemia and Lymphomas
9. Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data at ASCO
10. Cytogen Reports Publication Validating the Utility of its Proprietary ProChart Database
11. Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... Oct. 24, 2014  As the building blocks ... company access to diverse skill sets and expertise, ... clock business hours for efficiency. However, effectively managing ... According to recent research, more than ... seeing a project not move forward due to ...
(Date:10/22/2014)... , Oct. 22, 2014  Quest Diagnostics (NYSE: ... information services, today announced that its Board of Directors ... a director, effective December 1, 2014. Including Dr. Leiden, ... is the Chairman, President and CEO of Vertex Pharmaceuticals. ... scientific and commercial experience in the pharmaceutical and biotechnology ...
(Date:10/22/2014)... , Oct. 22, 2014   Reproductive ... world-renowned leader in the field of infertility, presents ... to embryonic screening. The research abstract, released during ... Reproductive Medicine (ASRM) meeting in Honolulu, ... and single gene defect (SGD) pre-implantation genetic diagnosis ...
Breaking Medicine Technology:Work Around the Clock: Successfully Building & Managing Global Virtual Teams 2Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 2Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 3New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 2New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 3
... , ALEXANDRIA, Va. , May 6 The National ... Reform and Transparency Act of 2010 , which would aim to ... managers (PBM) -- the largely unaccountable giant prescription drug plan administrators, ... Inc. , , , ...
... The U.S. Food and Drug Administration today approved Natazia, a combination hormonal ... , , ... , , ... and is the first four-phasic oral contraceptive marketed in the United States ...
Cached Medicine Technology:NCPA Applauds Rep. Weiner for Introducing Bill to Rein in Pharmacy Benefit Manager Practices That Hurt Patients, Plan Sponsors and Community Pharmacies 2NCPA Applauds Rep. Weiner for Introducing Bill to Rein in Pharmacy Benefit Manager Practices That Hurt Patients, Plan Sponsors and Community Pharmacies 3FDA Approves New Combination Product Oral Contraceptive 2
(Date:10/25/2014)... October 25, 2014 Mesothelioma researchers are ... to receive pemetrexed (Alimta), after his combination drug therapy ... full story , just posted on the Surviving Mesothelioma ... Tokushukai Medical Center in Japan suggests that “maintenance therapy” ... patients who cannot tolerate higher doses of cisplatin. ...
(Date:10/25/2014)... 2014 (HealthDay News) -- Not getting the right amount ... a new study suggests. Those who sleep less ... per night may be more prone to developing the ... report. The study authors concluded that duration and quality ... patients with inflammatory bowel diseases. "Both short and ...
(Date:10/25/2014)... Randy Dotinga HealthDay Reporter ... tests are developed that spot increased risks for certain cancers, ... about getting screened. But a new study suggests that, ... People who found out their genes doubled their risk of ... risk to get screened. "It didn,t make any difference, ...
(Date:10/22/2014)... TX (PRWEB) October 22, 2014 On ... Criminal Minds featuring skin diseases both fictional and ... (CEHMDF), a nonprofit organization committed to advocacy and ... if CBS will take the opportunity to impart truth ... , There are many misconceptions about ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, ... Ebola cases in Dallas. But, mental health specialists say overblown ... President Barack Obama on Friday appointed an Ebola "czar" to ... two Dallas nurses who cared for a Liberian man who ... But the U.S. cases are miniscule in the context ...
Breaking Medicine News(10 mins):Health News:New Report Illustrates Extended Mesothelioma Survival with “Maintenance Therapy”, According to Surviving Mesothelioma 2Health News:Sleep Duration Linked to Ulcerative Colitis Risk in Study 2Health News:Knowing Genetic Risk for Cancer May Not Change Behavior 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 2Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 3
... A drug whose clinical benefit in treating multiple sclerosis was ... Food and Drug Administration on January 22 and is now ... is the first therapy for multiple sclerosis that can be ... to treat impaired walking, a debilitating symptom of the disease ...
... ... renewed its multi year relationship with Seventh Generation, the leading global brand of green ... paper towels. , ... Hong Kong, China (April 1, 2010) – Serendipity House Limited, Hong Kong’s leading provider ...
... ... a new survey of U.S. healthcare organizations suggests that while organizations are updating their ... ... the healthcare industry prepares for a major shift to electronic health records (EHRs) over ...
... ... Techniques Are Impacting the Face of the Senior Care Industry , ... Newport Beach, Calif. (PRWEB) April 5, ... on how elder care marketers grow their businesses. The Elder Care Marketing Industry Report, ...
... discovered retrovirus, xenotropic murine leukemia virus-related virus (XMRV), has ... of conflicting data concerning XMRV, standardized diagnostic testing is ... and to determine whether it plays a role in ... the April issue of Urology is a ...
... Research on antibodies may aid vaccine development , MONDAY, April ... insight into how the body fights off HIV, a finding ... the virus, which causes AIDS. , At the moment, there,s ... develop a vaccine. HIV remains an extremely stubborn enemy. , ...
Cached Medicine News:Health News:Clinical benefit of multiple sclerosis drug discovered at Rush University Medical Center 2Health News:Clinical benefit of multiple sclerosis drug discovered at Rush University Medical Center 3Health News:Serendipity House Limited, the Leading Provider of Natural and Organic Products in Hong Kong, Renews Multi-year Relationship with Seventh Generation 2Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 2Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 3Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 4Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 5Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 6Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 7Health News:New Study on Elder Care Marketing Reveals Fresh Insights in Targeting Aging Population 2Health News:New Study on Elder Care Marketing Reveals Fresh Insights in Targeting Aging Population 3Health News:New investigation supports correlation between XMRV and prostate cancer 2Health News:Scientists Find Clues to How the Body Fights Off HIV 2
... Blood Collection Tubes were designed for ease ... a quality capillary blood sample is collected. ... Microgard Closure features an integrated collection scoop ... of microcollection tubes is available for hematology ...
... PT System is an in vitro diagnostic ... results, expressed in seconds and INR units. ... It is intended for use by health ... to monitor patients who are on warfarin-type ...
... IntelliVue Information Center combines the real-time ... with sophisticated clinical analysis tools. Moreover, ... Philips innovative portal technology so that ... by side with digital radiology images, ...
... GenS automates time-consuming tasks ... to help increase productivity and ... high-volume lab. It offers automated ... technology, which provides excellent sensitivity, ...
Medicine Products: